Inhibition and Degradation of Drug Targets Using bioPROTAC mRNAs – A Novel Approach with Broad Therapeutic Potential

Anthony Partridge, PhD

Senior Principal Scientist, Merck Sharpe and Dohme

Wednesday, May 1, 2019 - 2:00pm

PGCRL Event Room 1 (02.9320, 2nd Floor), 686 Bay St.

Invited Speaker Seminar

Host: 

Dr. Roman Melnyk

Molecular Medicine Seminar Series

Poster: 

MM Special Seminar - Anthony Partridge May 1st.pdf